nivolumab
bms
['remain trial', 'nivo', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'nivolumab']
#ash22 #leusm liu: median os 54 vs 31mo in nivo vs obs arm (not sig). more aes on nivo arm. another study in which aml hasn t succumbed to checkpoint inhibition, sadly. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)